BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12032775)

  • 1. Transcriptional regulation of erythropoiesis: an affair involving multiple partners.
    Cantor AB; Orkin SH
    Oncogene; 2002 May; 21(21):3368-76. PubMed ID: 12032775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
    Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
    Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of altered specificity mutants to probe specific protein-protein interactions involved in the activation of GATA-1 target genes.
    Crispino JD; Orkin SH
    Methods; 2002 Jan; 26(1):84-92. PubMed ID: 12054907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic over-expression of GATA-1 mutant lacking N-finger domain causes hemolytic syndrome in mouse erythroid cells.
    Nakano M; Ohneda K; Yamamoto-Mukai H; Shimizu R; Ohneda O; Ohmura S; Suzuki M; Tsukamoto S; Yanagawa T; Yoshida H; Takakuwa Y; Yamamoto M
    Genes Cells; 2005 Jan; 10(1):47-62. PubMed ID: 15670213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis.
    Chang AN; Cantor AB; Fujiwara Y; Lodish MB; Droho S; Crispino JD; Orkin SH
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9237-42. PubMed ID: 12077323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
    Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis.
    Shimizu R; Takahashi S; Ohneda K; Engel JD; Yamamoto M
    EMBO J; 2001 Sep; 20(18):5250-60. PubMed ID: 11566888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1: friends, brothers, and coworkers.
    Morceau F; Schnekenburger M; Dicato M; Diederich M
    Ann N Y Acad Sci; 2004 Dec; 1030():537-54. PubMed ID: 15659837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation.
    Watamoto K; Towatari M; Ozawa Y; Miyata Y; Okamoto M; Abe A; Naoe T; Saito H
    Oncogene; 2003 Dec; 22(57):9176-84. PubMed ID: 14668799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and transcriptional regulation of megakaryocyte differentiation.
    Shivdasani RA
    Stem Cells; 2001; 19(5):397-407. PubMed ID: 11553848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
    Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
    Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor GATA-1 in megakaryocyte development.
    Orkin SH; Shivdasani RA; Fujiwara Y; McDevitt MA
    Stem Cells; 1998; 16 Suppl 2():79-83. PubMed ID: 11012179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.
    Grosveld F; Rodriguez P; Meier N; Krpic S; Pourfarzad F; Papadopoulos P; Kolodziej K; Patrinos GP; Hostert A; Strouboulis J
    Ann N Y Acad Sci; 2005; 1054():55-67. PubMed ID: 16339652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
    Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
    Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
    Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic and functional determination of the interaction of Pb2+ with GATA proteins.
    Ghering AB; Jenkins LM; Schenck BL; Deo S; Mayer RA; Pikaart MJ; Omichinski JG; Godwin HA
    J Am Chem Soc; 2005 Mar; 127(11):3751-9. PubMed ID: 15771509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors.
    Lecine P; Shivdasani RA
    Stem Cells; 1998; 16 Suppl 2():91-5. PubMed ID: 11012181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex.
    Crispino JD; Lodish MB; MacKay JP; Orkin SH
    Mol Cell; 1999 Feb; 3(2):219-28. PubMed ID: 10078204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
    Zhang P; Zhang X; Iwama A; Yu C; Smith KA; Mueller BU; Narravula S; Torbett BE; Orkin SH; Tenen DG
    Blood; 2000 Oct; 96(8):2641-8. PubMed ID: 11023493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-1 forms distinct activating and repressive complexes in erythroid cells.
    Rodriguez P; Bonte E; Krijgsveld J; Kolodziej KE; Guyot B; Heck AJ; Vyas P; de Boer E; Grosveld F; Strouboulis J
    EMBO J; 2005 Jul; 24(13):2354-66. PubMed ID: 15920471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.